Salt Composition in both

Salt Composition

Sertraline 120mg(same for both)

You Searched

Strattera 80mg Tablet 15s

Novartis India Ltd.

Strip of 15 tablets

We only sell the best substitute from top brands

Our Recommendation

Suhagrai 80mg Tablet of 15s

Dr. Morepen Ltd.

576+ Customers trust this

WHO GMP Certified

Marketed by

Doctor ApprovedMedicine Comparison

Disclaimer

PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.

Top Selling Medicines

Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More

Top Selling Devices

Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s

Yes! of this pagePricesToxins

Search for a prescription

Unavailable

No prescription

If you don't have a prescription, you can access the medication directly on the website. In addition to not having to worry about looking in the name on the package, there are plenty of side effects with this medication. One of the most common ones is a low blood pressure that can be severe and even fatal. If you want to prevent these diseases, it is essential to check with your doctor before using this medication. This medication can lower your blood pressure, making it easier for you to get the medication you need. When using this medication, it is important to keep a check-up schedule with your doctor. This will help ensure that you don't have any problems while using this medication. There are some supplements that can be bought over-the-counter and others that can be purchased online. It is also important to note that not all patients are given this medication, and if you are having any problems, it is crucial to speak with your doctor. If you have any concerns about your treatment using this medication, you should consult your doctor.

Dynasty ofnames.pro

Health Information Multris

A blood pressure medication like this is very important to keep you stable and healthy. When used correctly, this medication can be very effective in lowering blood pressure.

Strattera (atomoxetine) is a prescription medicine that is used to treat narcolepsy and attention deficit hyperactivity disorder (ADHD).

According to a study in the Journal of Clinical Psychiatry, Strattera is the first and only treatment to help reduce the symptoms of ADHD.

It belongs to a class of drugs known as selective norepinephrine reuptake inhibitors (SNRIs), which help the brain to rewire attention, focus, and impulse control. Strattera also helps with hyperactivity in children and adults with ADHD. It can be used to treat ADHD in children ages 6 and older.

Strattera is a prescription medicine that is used to treat narcolepsy and attention deficit hyperactivity disorder (ADHD). It belongs to a group of drugs called selective norepinephrine reuptake inhibitors (SNRIs), which work by increasing the levels of norepinephrine in the brain. This helps to increase focus and improve concentration.

The study authors, Drs. Ramesh Dhanushal, D. P. Raju, and Shahbaz Ahmed, found that Strattera was effective in reducing hyperactivity in children with ADHD. The research also found that the drug did not affect the development of ADHD symptoms.

According to the study, Strattera may work in children with ADHD in the short term and long term by increasing norepinephrine levels in the brain, which is involved in attention regulation.

Strattera may also be used to treat hyperactivity in children with attention deficit hyperactivity disorder (ADHD). This medication is a non-stimulant, meaning it does not cause drowsiness.

The researchers also found that the drug did not affect attention and focus in children with ADHD.

In addition, the researchers also discovered that Strattera did not affect the levels of norepinephrine in the brain.

However, the drug does help the brain to rewire attention, focus, and impulse control. This may help to reduce hyperactivity in children with ADHD.

The research was published inThe Journal of Clinical Psychiatry. The research was done by Dr. Raju, and Shahbaz Ahmed, from the Department of Psychiatry, University of California, San Francisco, USA.

According to the study, Strattera was effective in reducing hyperactivity in children with ADHD.

The study authors, Dr.

Strattera Overview

Atomoxetine belongs to a group of drugs called selective norepinephrine reuptake inhibitors (SNRIs), which are used to treat.

Atomoxetine works by stopping the reuptake of norepinephrine, a neurotransmitter that is responsible for regulating mood, appetite, and other bodily functions in the brain.

This medication is a type of drug called a norepinephrine reuptake inhibitor (NRRI). By blocking the reuptake of norepinephrine, Atomoxetine prevents the reabsorption of norepinephrine in the brain. This results in increased levels of norepinephrine, which helps improve mood, sleep, appetite, and other bodily functions in the brain.

The drug's main active ingredient is atomoxetine hydrochloride (Strattera), which belongs to a group of medicines called Selective Serotonin Reuptake Inhibitors (SSRIs).

Strattera is usually taken orally, with or without food. It is usually taken once a day and can be taken with or without food.

Atomoxetine can also be taken in combination with other medicines. It is also available in a tablet form.

It is important to note that Atomoxetine is not a controlled substance and should only be used under the guidance and supervision of a healthcare professional.

How Does Atomoxetine Work?

Atomoxetine works by increasing the levels of norepinephrine in the brain. This results in increased norepinephrine activity in the central nervous system (CNS).

Atomoxetine helps to increase the level of norepinephrine in the brain and helps to improve mood, sleep, appetite, and other bodily functions in the brain.

It is available as a generic drug.

Strattera is available in the following forms:

Atomoxetine is also available as a capsule.

How to Take Atomoxetine?

Atomoxetine should be taken at least 1 hour before or 2 hours after meals. Do not take it with or without food.

If you miss a dose of Atomoxetine, skip it and take your next dose as scheduled. Do not take 2 doses at once.

What Are the Side Effects of Atomoxetine?

Atomoxetine is generally well-tolerated when used in combination with other medications. However, there are possible side effects that may occur.

Introduction to Atomoxetine HCL

Atomoxetine HCL, commonly known by its brand name Strattera, is a non-stimulant medication prescribed to treat Attention-Deficit Hyperactivity Disorder (ADHD). It works by increasing the levels of norepinephrine in the brain, which helps improve attention, focus, and impulse control[2].

Global Market Size and Growth

The global Atomoxetine HCL API market is experiencing significant growth, driven by several key factors:

• Rising ADHD Diagnosis Rates: The increasing prevalence of ADHD diagnoses is a major driver of the market. As more cases are identified and treated, the demand for effective medications like Atomoxetine HCL is on the rise[1][3][4].
• Market Size and Forecast: As of 2024, the global Atomoxetine HCL API market size is estimated at USD xx million. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.00% from 2024 to 2031, reaching USD xx million by 2031[1].

Key Drivers

Several factors are driving the growth of the global Atomoxetine HCL API market:

Increasing Prevalence of ADHD

The global ADHD market is believed to be tackled by increasing awareness of disorders such as ADHD, and Strattera's ability to treat these symptoms. This in turn, increases diagnostic accuracy and helps in on-demand treatment[1][3][4].

Advancements in Pharmaceutical Technologies

The introduction of innovative formulations and newer therapies has increased treatment options for ADHD, which have further complicates the demand for Atomoxetine HCL[1].

The increase in the use of stimulant medications and the depletion of active ingredients in psychiatric drugs is putting pressure on the supply chain, leading to a more extensive supply chain strain. This has the further increase in the demand for Atomoxetine HCL[1].

Aging Population

The growing elderly population, which is more vulnerable to psychiatric disorders, is a significant driver of the market. This is due to a higher rate of fractures andROA, which are common symptoms of dementia[1].

Aware of Attention Deficit Hyperactivity Disorder (ADD)

Another critical market pressure is an aging population, which is increasing the likelihood of ADHD diagnoses due to its dependence on stimulants and other medications. Strattera's ability to treat attention deficit hyperactivity disorder (ADHD) has enabled the market to grow in 2022. This has led to growing demand for effective ADHD medication[1].

Market Segmentation

This segmentation is crucial for the market TO X 2031:

• Adults: This group includes those who are under the supervision of a doctor and/or have apolyneuropathy disorder. They can benefit from a stronger sedative/hypnostatic comp known as neuroleptic malignant syndrome (NMS)[1].
• Children: These groups have a lower prevalence of ADHD due to the smaller prefrontal cortex volume, leading to a lower demand for medication[1].

Detailed Characteristics of the Market

• : xx million market size
• : 4Q 2022 2023Q 20Q 20Q

Regional Analysis

The global Atomoxetine HCL API market is segmented based on:

• North America: 6Q 2031
• Asia-Pacific: 3Q 2022 2031
• Middle East and Africa: 0Q 2031

North America holds a significant share of the global Atomoxetine HCL API market. This can be due to the high rate of fractures andROA that are common symptoms of dementia. This can in turn influence the demand for effective ADHD medication[1][3][4].

INDICATIONS

ADHD: primary hyperphosphothiazide (Atomoxetine) and stimulant (Strattera) is used in the treatment of attention-deficit/hyperactivity disorder (ADHD) and in the treatment of attention deficit hyperactivity disorder (ADHD/AD). It is also used for narcolepsy and for the treatment of attention-deficit/hyperactivity disorder (ADHD).

ADHD/AD: primary hyperphosphothiazide (Atomoxetine) and stimulant (Strattera) is used in the treatment of ADHD and in the treatment of ADHD-related problems in adults with the disorder. It is also used in children, adolescents and the elderly.

INSTRUCTIONS

ADHD/ADHD-related problems in adults:Symptom onsetThe main symptom of ADHD is the inability to get and/or keep an adequate level of energy. In people with ADHD, the main symptom is attention problems.

ADHD/ADHD-related problems in children:A stimulant (like Strattera) is used in the treatment of ADHD and in the treatment of ADHD-related problems in children.

An abnormal or absent feeling or speech. In people with ADHD-related problems in adults, attention problems are a side effect of the ADHD medication.

A stimulant (like Strattera) is used in the treatment of ADHD and in the treatment of ADHD-related problems in adults.

The following information is provided to increase the effect of this product: The dosage of the active ingredient of the product is dependent on the dosage form.

OVERDOSAGE

The condition can be affected by other medical conditions and other conditions as follows:

• Allergic reactions: if any of the following occur, such as an allergic reaction occurs, the patient should stop the use of the medicine, and the patient is advised to seek medical help,
• Allergic reaction of the nervous system: any of the following symptoms occur, such as trouble breathing, a severe or prolonged convulsions, severe headache, dizziness, confusion, trouble speaking, trouble remembering, abnormal or irregular heartbeat, fast or irregular heartbeat, difficulty with speech, fainting, shortness of breath, slow or shallow breathing, chest pain, swelling of face, lips, tongue or throat, dizziness, or weakness,
• Allergic reaction of the nervous system: any of the following symptoms occur, such as trouble breathing, a severe or prolonged convulsions, severe headache, dizziness, confusion, trouble talking, slow or shallow breathing, slow or shallow heartbeat, fast or irregular heartbeat, fast or irregular heartbeat, fever, itching, vomiting, irritability, or numbness of the face, lips, tongue, or throat, or swelling of the lips, tongue or face.

During the treatment of any medical condition a patient may become addicted to the drug. In this case, the treatment will be withdrawn from the drug.

DOSAGE OF THIS PRODUCT

The dosage of the active ingredient of the product is dependent on the dosage form. The dosage form is provided as follows:

Tablet Strength: 40mgStrength: 40mg

Dosage: 40mg

Package Size: 30gStrength: 30mg

Pack Size: 30g

Pack Type: 30g

Pack size: 30g

OVERDOSAGE AND INITIATION

In children, attention problems are a side effect of the ADHD medication.